Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

RomaniaBack to Romania

Clinical trials in Pascani

3 clinical trials in Pascani, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.

RomaniaOur site in RomaniaStudii.Clinice.ro(opens in a new tab)
Pascani at a glance
3
clinical trials
  • Recruiting now0
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

3 trials in Pascani

Open in trial search

Cardiac failure

Not recruiting
Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Type 2 diabetes mellitus

Not recruiting
Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Chronic kidney disease+1

Not recruiting
Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Other cities in Romania

The busiest research cities in the country

All 63 cities in Romania

Clinical research in Pascani

What the registry says about research in the country

01 Pascani
Cardiovascular Diseases and Metabolic Disorders
Clinical research in Pascani is centered on cardiovascular diseases and nutritional and metabolic diseases, with studies recruiting patients for conditions linked to inflammation, heart function, and blood sugar control. These trials are exploring whether new treatments can improve outcomes for people with complex long-term illness. Heart failure with mildly reduced or preserved ejection fraction and related inflammation Atherosclerotic cardiovascular disease with chronic kidney disease and systemic inflammation Type 2 diabetes with inadequate glycaemic control The main purpose of this research is to test whether emerging therapies can reduce cardiovascular events, improve heart-related outcomes, and strengthen control of metabolic disease.
Inflammation-Related Heart Failure Research
One set of trials focuses on heart failure and the role of systemic inflammation, looking at whether a new treatment can better protect patients from serious heart-related complications compared with standard care. Heart failure with mildly reduced ejection fraction Heart failure with preserved ejection fraction Systemic inflammation as a key factor in disease progression The research aims to improve treatment effectiveness for people whose heart failure is closely connected to inflammation.
Diabetes and Glycaemic Control
Another trial area in this city examines type 2 diabetes, with a strong focus on lowering blood sugar and supporting better overall metabolic control in people who are not responding well enough to current treatment. Type 2 diabetes HbA1c improvement Metabolic management alongside standard diabetes care The goal is to evaluate whether newer therapy options can outperform established treatment in helping patients achieve better glucose control.
Atherosclerotic Disease and Kidney Involvement
Research also includes patients with established atherosclerotic cardiovascular disease and chronic kidney disease, especially when both are accompanied by ongoing inflammation. These studies are designed to see if a new approach can lower major cardiovascular risks more effectively than placebo-based standard care. Atherosclerotic cardiovascular disease Chronic kidney disease Systemic inflammation linked to higher cardiovascular risk This work is aimed at reducing the risk of serious events such as heart attack, stroke, and cardiovascular death in high-risk patients.
Back to RomaniaAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.